V-Square Quantitative Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Sell
4,302
-141
-3% -$71.3K 0.21% 74
2025
Q4
$2.52M Buy
+4,443
New +$2.37M 0.26% 57
2025
Q3
Sell
-4,873
Closed -$2.65M 365
2025
Q2
$2.65M Buy
4,873
+1,170
+32% +$612K 0.35% 49
2025
Q1
$1.83M Buy
3,703
+23
+0.6% +$12.7K 0.27% 71
2024
Q4
$1.92M Buy
3,680
+157
+4% +$81.8K 0.27% 66
2024
Q3
$1.73M Buy
3,523
+483
+16% +$225K 0.25% 72
2024
Q2
$1.35M Sell
3,040
-780
-20% -$311K 0.22% 78
2024
Q1
$1.52M Buy
3,820
+1,414
+59% +$534K 0.21% 70
2023
Q4
$812K Buy
2,406
+1,012
+73% +$302K 0.14% 113
2023
Q3
$407K Buy
1,394
+551
+65% +$172K 0.18% 122
2023
Q2
$288K Buy
843
+50
+6% +$15.1K 0.21% 98
2023
Q1
$203K Buy
+793
New +$195K 0.19% 135

Other funds holding ISRG

V-Square Quantitative Management's ISRG Position: Q1 2026 in Review

V-Square Quantitative Management reduced its Intuitive Surgical (ISRG) stake by 3.2% in Q1 2026, selling an estimated $71.3K and leaving 4,302 shares worth $1.98M. The position accounts for 0.21% of the portfolio, ranked #74.

V-Square Quantitative Management first reported a position in ISRG in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.65M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • V-Square Quantitative Management held 4,302 shares of Intuitive Surgical worth $1.98M as of Q1 2026.
  • V-Square Quantitative Management sold 141 Intuitive Surgical shares in Q1 2026, an estimated $71.3K.
  • Intuitive Surgical made up 0.21% of V-Square Quantitative Management's portfolio in Q1 2026, its #74 holding.
  • V-Square Quantitative Management first reported a position in Intuitive Surgical in Q1 2023 and has held it in 12 quarters since.
  • V-Square Quantitative Management's Intuitive Surgical position peaked at $2.65M in Q2 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.